Current status of percutaneous coronary intervention in patients with atrial fibrillation: The Fushimi AF Registry

Mitsuru Abe1, Nobutoyo Masunaga1, Mitsuru Ishii1

  • 1Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Journal of Cardiology
|November 8, 2019
PubMed

Insights

Approximately 1% of atrial fibrillation patients undergo percutaneous coronary intervention annually. Higher CHADS2 scores, particularly due to diabetes, are linked to increased PCI incidence in these patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Epidemiology

Background:

  • Optimal antithrombotic therapy for atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI) remains uncertain.
  • Choosing antithrombotic therapy post-PCI for AF patients on oral anticoagulants is challenging, especially with high CHADS2 scores.
  • Data on PCI incidence in AF patients are limited.

Purpose of the Study:

  • To evaluate the incidence of PCI procedures in AF patients.
  • To assess the association between PCI and the CHADS2 score in AF patients.
  • To identify specific risk factors within the CHADS2 score associated with PCI.

Main Methods:

  • Utilized data from the Fushimi AF Registry, a community-based prospective cohort study.
  • Followed 4325 AF patients with a median follow-up of 3.6 years.
  • Analyzed the incidence of PCI procedures and their correlation with CHADS2 scores and individual risk factors.

Main Results:

  • 143 PCI procedures were performed in 122 patients (crude incidence 9.36 per 1000 person-years).
  • Cumulative PCI incidence was 1.1% at 1 year and 2.4% at 3 years.
  • Patients with CHADS2 score ≥2 had a higher incidence of PCI compared to those with a score ≤1. Diabetes mellitus was significantly associated with PCI (HR, 1.95).

Conclusions:

  • About 1% of AF patients undergo PCI annually.
  • Higher CHADS2 scores are associated with increased PCI incidence in AF patients.
  • Diabetes mellitus is a significant predictor of PCI procedures in AF patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
191
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
675